Blueprint Medicines Corp (NASDAQ:BPMC)

94.94
Delayed Data
As of May 07
 +1.76 / +1.89%
Today’s Change
58.32
Today|||52-Week Range
125.61
-15.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line-72.7M-80.3M-87.4M-99.7M
 
 
 
 
 
Depreciation1.2M1.2M2.2M2.5M
 
 
 
 
 
Total Other Cash Flow7.1M7.4M9.0M12.0M
 
 
 
 
 
Funds From Operations-64.4M-71.8M-76.2M-85.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-9.4M-4.2M4.0M-5.5M
 
 
 
 
 
Net Cash Flow - Operating Activities-55.0M-67.6M-80.2M-79.7M
 
 
 
 
 
 
InvestingIncrease In Investments-159.6M-152.3M-112.9M-352.4M
 
 
 
 
 
Decrease In Investments178.8M209.0M204.0M106.5M
 
 
 
 
 
Capital Expenditures-2.6M-425.0K-1.8M-2.2M
 
 
 
 
 
Net Cash Flow Investing16.6M56.2M89.3M-248.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00-1.6M
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-498.0K-320.0K0.000.00
 
 
 
Net Proceeds Stock Sale611.0K1.1M2.0M332.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.0028.0K44.0K
 
 
 
Net Cash Flow - Financing113.0K764.0K2.0M330.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash------3.0K
 
 
 
Net Change In Cash-38.3M-10.6M11.1M3.0M